Ligand validation:1DAZ

0Q4: N-[(2R)-2-({N~5~-[amino(iminio)methyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucinamide

0Q4 is a Ligand Of Interest in 1DAZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1DAZ_0Q4_D_601	36%	54%	0.175	0.867	0.93	0.85	2	2	0	0	100%	0.5
6O48_0Q4_B_201	60%	43%	0.124	0.909	0.88	1.33	1	9	8	0	100%	1
1K2C_0Q4_B_401	51%	23%	0.146	0.898	0.95	2.18	1	6	5	0	100%	1
1DW6_0Q4_D_401	31%	54%	0.189	0.856	0.98	0.8	2	2	5	0	100%	1
1K2B_0Q4_A_401	17%	10%	0.245	0.823	0.89	3.42	1	3	2	0	100%	0.8
5KQZ_0Q4_B_101	11%	18%	0.242	0.762	2.58	0.99	13	2	17	0	100%	1
6O5X_0Q4_D_101	80%	32%	0.104	0.953	1.21	1.46	8	11	0	0	100%	0.9407

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.